Enterome, a clinical-stage biopharmaceutical company developing novel immunotherapies for cancer, has announced that the US ...

Medicus Pharma, a biotech and life sciences company developing novel and disruptive therapeutics, has announced the enrolment ...

Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific ...

Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance ...

At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications ...

Pharmaceutical companies can help facilitate patient pathway stakeholder engagement by partnering with patients, providers ...

The GPPG is more than a publication – it’s a movement towards truly patient- centric and accessible healthcare. It aims to ...

GSK has received approval from the US Food and Drug Administration (FDA) for Blenrep (belantamab mafodotin-blmf) in ...

Medherant, a clinical-stage company developing treatments using a novel transdermal drug delivery technology, has reported ...

Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s ...

Macmillan Cancer Support and 11 NHS Trusts have jointly published a report highlighting the benefits of prehabilitation ...

Novartis has agreed to acquire Avidity Biosciences, a San Diego-based biopharmaceutical company developing therapies for rare ...